AptaBio Therapeutics Inc. (KOSDAQ:293780)

AptaBio Therapeutics Statistics

Total Valuation

KOSDAQ:293780 has a market cap or net worth of KRW 213.58 billion. The enterprise value is 199.50 billion.

Market Cap	213.58B
Enterprise Value	199.50B

Important Dates

The last earnings date was Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:293780 has 27.92 million shares outstanding. The number of shares has increased by 10.95% in one year.

Current Share Class	26.88M
Shares Outstanding	27.92M
Shares Change (YoY)	+10.95%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	27.39%
Owned by Institutions (%)	2.81%
Float	18.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	68.71
PB Ratio	4.50
P/TBV Ratio	4.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.92
EV / Sales	64.18
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-13.35

Financial Position

The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.18.

Current Ratio	1.46
Quick Ratio	1.31
Debt / Equity	0.18
Debt / EBITDA	n/a
Debt / FCF	-0.57
Interest Coverage	-7.82

Financial Efficiency

Return on equity (ROE) is -51.36% and return on invested capital (ROIC) is -20.23%.

Return on Equity (ROE)	-51.36%
Return on Assets (ROA)	-15.62%
Return on Invested Capital (ROIC)	-20.23%
Return on Capital Employed (ROCE)	-38.56%
Revenue Per Employee	75.82M
Profits Per Employee	-614.27M
Employee Count	41
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

In the past 12 months, KOSDAQ:293780 has paid 1.57 billion in taxes.

Income Tax	1.57B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +20.66% in the last 52 weeks. The beta is 1.34, so KOSDAQ:293780's price volatility has been higher than the market average.

Beta (5Y)	1.34
52-Week Price Change	+20.66%
50-Day Moving Average	7,798.40
200-Day Moving Average	7,809.95
Relative Strength Index (RSI)	52.05
Average Volume (20 Days)	219,543

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:293780 had revenue of KRW 3.11 billion and -25.19 billion in losses. Loss per share was -994.81.

Revenue	3.11B
Gross Profit	623.01M
Operating Income	-19.80B
Pretax Income	-23.61B
Net Income	-25.19B
EBITDA	-19.28B
EBIT	-19.80B
Loss Per Share	-994.81

Balance Sheet

The company has 22.57 billion in cash and 8.50 billion in debt, giving a net cash position of 14.08 billion or 504.15 per share.

Cash & Cash Equivalents	22.57B
Total Debt	8.50B
Net Cash	14.08B
Net Cash Per Share	504.15
Equity (Book Value)	47.50B
Book Value Per Share	1,701.40
Working Capital	8.37B

Cash Flow

In the last 12 months, operating cash flow was -14.66 billion and capital expenditures -278.66 million, giving a free cash flow of -14.94 billion.

Operating Cash Flow	-14.66B
Capital Expenditures	-278.66M
Free Cash Flow	-14.94B
FCF Per Share	-535.15

Margins

Gross Margin	20.04%
Operating Margin	-637.10%
Pretax Margin	-759.55%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KOSDAQ:293780 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.95%
Shareholder Yield	-10.95%
Earnings Yield	-11.79%
FCF Yield	-7.00%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 24, 2021. It was a forward split with a ratio of 2.

Last Split Date	Aug 24, 2021
Split Type	Forward
Split Ratio	2

Scores

KOSDAQ:293780 has an Altman Z-Score of 2.47 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.47
Piotroski F-Score	2